239 related articles for article (PubMed ID: 12865039)
21. Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes.
Shigihara T; Sato A; Hayashi K; Saruta T
Hypertens Res; 2000 May; 23(3):219-26. PubMed ID: 10821130
[TBL] [Abstract][Full Text] [Related]
22. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
Holzgreve H; Nakov R; Beck K; Janka HU
Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200
[TBL] [Abstract][Full Text] [Related]
24. Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension.
Reynolds NA; Wagstaff AJ; Keam SJ
Drugs; 2005; 65(13):1893-914. PubMed ID: 16114984
[TBL] [Abstract][Full Text] [Related]
25. Prevention of microalbuminuria in type 2 diabetes: millimeters or milligrams?
Glassock RJ
J Am Soc Nephrol; 2006 Dec; 17(12):3276-8. PubMed ID: 17108313
[No Abstract] [Full Text] [Related]
26. Preventing microalbuminuria in patients with type 2 diabetes.
Jermendy G; Ruggenenti P
Diabetes Metab Res Rev; 2007 Feb; 23(2):100-10. PubMed ID: 17094161
[TBL] [Abstract][Full Text] [Related]
27. PAIT-Survey Follow-Up: Changes in Albuminuria in Hypertensive Diabetic Patients with Mild-Moderate Chronic Kidney Disease.
Fici F; Ari Bakir E; Ilkay Yüce E; Kanuncu S; Makel W; Tarim BA; Robles NR
High Blood Press Cardiovasc Prev; 2020 Feb; 27(1):43-49. PubMed ID: 31916208
[TBL] [Abstract][Full Text] [Related]
28. The fixed combination of verapamil SR/trandolapril.
Widimský J
Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
[TBL] [Abstract][Full Text] [Related]
29. Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group.
DeQuattro V; Lee D
Am J Hypertens; 1997 Jul; 10(7 Pt 2):138S-145S. PubMed ID: 9231890
[TBL] [Abstract][Full Text] [Related]
30. Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.
Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Sekizuka K; Ebihara I; Koide H
Am J Nephrol; 2000; 20(5):373-9. PubMed ID: 11092994
[TBL] [Abstract][Full Text] [Related]
31. Dissociation between blood pressure reduction and fall in proteinuria in primary renal disease: a randomized double-blind trial.
PROCOPA Study Group
J Hypertens; 2002 Apr; 20(4):729-37. PubMed ID: 11910310
[TBL] [Abstract][Full Text] [Related]
32. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
Ruilope LM; Usan L; Segura J; Bakris GL
J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814
[TBL] [Abstract][Full Text] [Related]
33. Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT).
Ruggenenti P; Iliev I; Costa GM; Parvanova A; Perna A; Giuliano GA; Motterlini N; Ene-Iordache B; Remuzzi G;
Diabetes Care; 2008 Aug; 31(8):1629-34. PubMed ID: 18443191
[TBL] [Abstract][Full Text] [Related]
34. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
Bakris GL; Toto RD; McCullough PA
J Hum Hypertens; 2005 Feb; 19(2):139-44. PubMed ID: 15457206
[TBL] [Abstract][Full Text] [Related]
35. Natural history of early diabetic nephropathy: what are the effects of therapeutic intervention? Melbourne Diabetic Nephropathy Study Group.
Jerums G; Allen TJ; Gilbert RE; Hammond J; Cooper ME; Campbell DJ; Raffaele J
J Diabetes Complications; 1995; 9(4):308-14. PubMed ID: 8573754
[TBL] [Abstract][Full Text] [Related]
36. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
37. BENEDICT in the treatment of hypertension.
Logan A
Curr Hypertens Rep; 2005 Apr; 7(2):121-3. PubMed ID: 15748536
[No Abstract] [Full Text] [Related]
38. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH
Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341
[TBL] [Abstract][Full Text] [Related]
39. Fixed combination verapamil SR/trandolapril.
Dooley M; Goa KL
Drugs; 1998 Nov; 56(5):837-44; discussion 845-6. PubMed ID: 9829157
[TBL] [Abstract][Full Text] [Related]
40. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Laffel LM; McGill JB; Gans DJ
Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
